Advertisement

Topics

Ipsen Announces Dysport® (abobotulinumtoxinA) Data Presentations Highlighting Duration of Response and Potential Benefit of Repeated Treatment in Spasticity

11:15 EST 15 Feb 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Oral Presentations at the 2018 Annual Meeting of the Association of Academic Physiatrists (AAP) Provide Additional Data on the Safety and Efficacy of Dysport® in Adults with Upper and Lower Limb Spasticity and Children with Low...

Other Sources for this Article

Marisol Peron
Vice President, North American
Internal & External Communications
908-275-6330
E-mail: marisol.peron@ipsen.com
or
Chamberlain Healthcare PR
Lisa Vanella, 212-849-9476
E-mail: lisa.vanella@inventivhealth.com

NEXT ARTICLE

More From BioPortfolio on "Ipsen Announces Dysport® (abobotulinumtoxinA) Data Presentations Highlighting Duration of Response and Potential Benefit of Repeated Treatment in Spasticity"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...